Siga Technologies (SIGA) Cash from Investing Activities Growth (3y) (2013 - 2024)
Powered by 
Analysis
Siga Technologies (SIGA) Cash from Investing Activities Growth (3y) (2013 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 33.51% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | -51.98% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 21.19% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -47.89% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 27.70% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | -91.04% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 33.61% |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 12.02% |
| Jun 30, 2024 | 41.11% |
| Dec 31, 2021 | -26.00% |
| Jun 30, 2021 | 27.31% |
| Dec 31, 2019 | -25.99% |
| Sep 30, 2019 | -2,621.01% |
| Jun 30, 2019 | 26.02% |
| Mar 31, 2019 | -1.84% |
| Dec 31, 2018 | 1,096.13% |
| Dec 31, 2017 | -177.29% |
| Sep 30, 2017 | 84.45% |
| Jun 30, 2017 | -27.55% |
| Dec 31, 2016 | 83.16% |
| Sep 30, 2016 | 25.99% |
| Jun 30, 2016 | 69.62% |
| Mar 31, 2016 | 68.40% |
| Dec 31, 2015 | 47.95% |
| Sep 30, 2015 | -51.22% |
| Mar 31, 2015 | 187.69% |
| Dec 31, 2014 | 74.85% |